HEADER HYDROLASE/HYDROLASE INHIBITOR 09-MAY-12 4F3C TITLE CRYSTAL STRUCTURE OF 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE TITLE 2 NUCLEOSIDASE FROM SALMONELLA ENTERICA WITH BUTYL-THIO-DADME- TITLE 3 IMMUCILLIN-A COMPND MOL_ID: 1; COMPND 2 MOLECULE: 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MTA/SAH NUCLEOSIDASE, MTAN, 5'-METHYLTHIOADENOSINE COMPND 5 NUCLEOSIDASE, S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE; COMPND 6 EC: 3.2.2.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR SOURCE 3 CHOLERAESUIS; SOURCE 4 ORGANISM_TAXID: 904139; SOURCE 5 STRAIN: SCSA50; SOURCE 6 GENE: EMBL EFZ04802.1, MTNN, PFS, SCA50_0219; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PDEST14 KEYWDS L-METHIONINE BIOSYNTHETIC PROCESS FROM S-ADENOSYLMETHIONINE, L- KEYWDS 2 METHIONINE SALVAGE FROM METHYLTHIOADENOSINE, 5'- KEYWDS 3 METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE, KEYWDS 4 ADENOSYLHOMOCYSTEINE NUCLEOSIDASE ACTIVITY, METHYLTHIOADENOSINE KEYWDS 5 NUCLEOSIDASE ACTIVITY, ACTING ON GLYCOSYL BONDS, HYDROLASE-HYDROLASE KEYWDS 6 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.M.HAAPALAINEN,K.THOMAS,J.B.BONANNO,S.C.ALMO,V.L.SCHRAMM REVDAT 3 28-FEB-24 4F3C 1 REMARK SEQADV REVDAT 2 19-JUN-13 4F3C 1 JRNL REVDAT 1 01-MAY-13 4F3C 0 JRNL AUTH A.M.HAAPALAINEN,K.THOMAS,P.C.TYLER,G.B.EVANS,S.C.ALMO, JRNL AUTH 2 V.L.SCHRAMM JRNL TITL CRYSTAL STRUCTURE OF JRNL TITL 2 5'-METHYLTHIOADENOSINE/S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASE JRNL TITL 3 FROM SALMONELLA ENTERICA WITH BUTYL-THIO-DADME-IMMUCILLIN-A JRNL REF STRUCTURE V. 21 963 2013 JRNL REFN ISSN 0969-2126 JRNL PMID 23685211 JRNL DOI 10.1016/J.STR.2013.04.009 REMARK 2 REMARK 2 RESOLUTION. 1.93 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0025 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.93 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.46 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 29019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1538 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.93 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2089 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2670 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.3180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3404 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.72000 REMARK 3 B22 (A**2) : 2.13000 REMARK 3 B33 (A**2) : -0.27000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.02000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.185 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.163 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.120 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.236 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.954 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3577 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3528 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4860 ; 1.385 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8114 ; 0.764 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 480 ; 5.977 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 145 ;37.374 ;25.310 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 601 ;13.041 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;25.658 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 587 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4083 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 761 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4F3C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072402. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK DOUBLE CRYSTAL REMARK 200 SAGITTAL FOCUSING MONOCHROMETER REMARK 200 AND VERTICAL FOCUSING MIRROR REMARK 200 OPTICS : ROSENBAUM-ROCK DOUBLE CRYSTAL REMARK 200 SAGITTAL FOCUSING MONOCHROMETER REMARK 200 AND VERTICAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30569 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.930 REMARK 200 RESOLUTION RANGE LOW (A) : 64.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06900 REMARK 200 R SYM (I) : 0.06900 REMARK 200 FOR THE DATA SET : 11.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.93 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.25300 REMARK 200 R SYM FOR SHELL (I) : 0.25300 REMARK 200 FOR SHELL : 4.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2M LITHIUM ACETATE, PH REMARK 280 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 23.30500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 GLY A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 231 REMARK 465 GLY A 232 REMARK 465 MET B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 HIS B -9 REMARK 465 GLY B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 HIS B 231 REMARK 465 GLY B 232 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 149 38.20 -93.35 REMARK 500 SER A 155 -151.43 53.54 REMARK 500 GLU A 172 -157.96 -152.90 REMARK 500 GLU A 174 -31.00 -134.69 REMARK 500 ASN A 186 54.00 39.54 REMARK 500 LYS B 67 63.71 36.08 REMARK 500 ASP B 149 39.89 -86.91 REMARK 500 ASN B 153 54.68 -146.43 REMARK 500 SER B 155 -143.33 56.73 REMARK 500 GLU B 172 -159.14 -154.96 REMARK 500 GLU B 174 -30.85 -134.30 REMARK 500 ASP B 200 -161.90 -100.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BIG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BIG B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4F1W RELATED DB: PDB REMARK 900 RELATED ID: 4F2P RELATED DB: PDB REMARK 900 RELATED ID: 4F2W RELATED DB: PDB REMARK 900 RELATED ID: 4F3K RELATED DB: PDB DBREF 4F3C A 1 232 UNP E8NLP5 E8NLP5_SALET 1 232 DBREF 4F3C B 1 232 UNP E8NLP5 E8NLP5_SALET 1 232 SEQADV 4F3C MET A -15 UNP E8NLP5 INITIATING METHIONINE SEQADV 4F3C HIS A -14 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A -13 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A -12 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A -11 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A -10 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A -9 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY A -8 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY A -7 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C LEU A -6 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C VAL A -5 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C PRO A -4 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C ARG A -3 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY A -2 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C SER A -1 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS A 0 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C MET B -15 UNP E8NLP5 INITIATING METHIONINE SEQADV 4F3C HIS B -14 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B -13 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B -12 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B -11 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B -10 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B -9 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY B -8 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY B -7 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C LEU B -6 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C VAL B -5 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C PRO B -4 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C ARG B -3 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C GLY B -2 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C SER B -1 UNP E8NLP5 EXPRESSION TAG SEQADV 4F3C HIS B 0 UNP E8NLP5 EXPRESSION TAG SEQRES 1 A 248 MET HIS HIS HIS HIS HIS HIS GLY GLY LEU VAL PRO ARG SEQRES 2 A 248 GLY SER HIS MET LYS ILE GLY ILE ILE GLY ALA MET GLU SEQRES 3 A 248 GLU GLU VAL THR LEU LEU ARG ASP LYS ILE ASP ASN ARG SEQRES 4 A 248 GLN THR ILE THR LEU GLY GLY CYS GLU ILE TYR THR GLY SEQRES 5 A 248 GLN LEU ASN GLY THR GLU VAL ALA LEU LEU LYS SER GLY SEQRES 6 A 248 ILE GLY LYS VAL ALA ALA ALA LEU GLY ALA THR LEU LEU SEQRES 7 A 248 LEU GLU HIS CYS LYS PRO ASP VAL ILE ILE ASN THR GLY SEQRES 8 A 248 SER ALA GLY GLY LEU ALA SER THR LEU LYS VAL GLY ASP SEQRES 9 A 248 ILE VAL VAL SER ASP GLU THR ARG TYR HIS ASP ALA ASP SEQRES 10 A 248 VAL THR ALA PHE GLY TYR GLU TYR GLY GLN LEU PRO GLY SEQRES 11 A 248 CYS PRO ALA GLY PHE LYS ALA ASP ASP LYS LEU ILE ALA SEQRES 12 A 248 ALA ALA GLU SER CYS ILE ARG GLU LEU ASN LEU ASN ALA SEQRES 13 A 248 VAL ARG GLY LEU ILE VAL SER GLY ASP ALA PHE ILE ASN SEQRES 14 A 248 GLY SER VAL GLY LEU ALA LYS ILE ARG HIS ASN PHE PRO SEQRES 15 A 248 ASP ALA VAL ALA VAL GLU MET GLU ALA THR ALA ILE ALA SEQRES 16 A 248 HIS VAL CYS HIS ASN PHE ASN VAL PRO PHE VAL VAL VAL SEQRES 17 A 248 ARG ALA ILE SER ASP VAL ALA ASP GLN GLN SER HIS LEU SEQRES 18 A 248 SER PHE ASP GLU PHE LEU ALA VAL ALA ALA LYS GLN SER SEQRES 19 A 248 THR LEU MET VAL GLU THR LEU VAL GLN LYS LEU ALA HIS SEQRES 20 A 248 GLY SEQRES 1 B 248 MET HIS HIS HIS HIS HIS HIS GLY GLY LEU VAL PRO ARG SEQRES 2 B 248 GLY SER HIS MET LYS ILE GLY ILE ILE GLY ALA MET GLU SEQRES 3 B 248 GLU GLU VAL THR LEU LEU ARG ASP LYS ILE ASP ASN ARG SEQRES 4 B 248 GLN THR ILE THR LEU GLY GLY CYS GLU ILE TYR THR GLY SEQRES 5 B 248 GLN LEU ASN GLY THR GLU VAL ALA LEU LEU LYS SER GLY SEQRES 6 B 248 ILE GLY LYS VAL ALA ALA ALA LEU GLY ALA THR LEU LEU SEQRES 7 B 248 LEU GLU HIS CYS LYS PRO ASP VAL ILE ILE ASN THR GLY SEQRES 8 B 248 SER ALA GLY GLY LEU ALA SER THR LEU LYS VAL GLY ASP SEQRES 9 B 248 ILE VAL VAL SER ASP GLU THR ARG TYR HIS ASP ALA ASP SEQRES 10 B 248 VAL THR ALA PHE GLY TYR GLU TYR GLY GLN LEU PRO GLY SEQRES 11 B 248 CYS PRO ALA GLY PHE LYS ALA ASP ASP LYS LEU ILE ALA SEQRES 12 B 248 ALA ALA GLU SER CYS ILE ARG GLU LEU ASN LEU ASN ALA SEQRES 13 B 248 VAL ARG GLY LEU ILE VAL SER GLY ASP ALA PHE ILE ASN SEQRES 14 B 248 GLY SER VAL GLY LEU ALA LYS ILE ARG HIS ASN PHE PRO SEQRES 15 B 248 ASP ALA VAL ALA VAL GLU MET GLU ALA THR ALA ILE ALA SEQRES 16 B 248 HIS VAL CYS HIS ASN PHE ASN VAL PRO PHE VAL VAL VAL SEQRES 17 B 248 ARG ALA ILE SER ASP VAL ALA ASP GLN GLN SER HIS LEU SEQRES 18 B 248 SER PHE ASP GLU PHE LEU ALA VAL ALA ALA LYS GLN SER SEQRES 19 B 248 THR LEU MET VAL GLU THR LEU VAL GLN LYS LEU ALA HIS SEQRES 20 B 248 GLY HET BIG A 301 23 HET EDO A 302 4 HET BIG B 301 23 HET EDO B 302 4 HET EDO B 303 4 HETNAM BIG (3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL) HETNAM 2 BIG METHYL]-4-[(BUTYLSULFANYL)METHYL]PYRROLIDIN-3-OL HETNAM EDO 1,2-ETHANEDIOL HETSYN BIG BUTYLTHIO-DADME-IMMUCILLIN A HETSYN EDO ETHYLENE GLYCOL FORMUL 3 BIG 2(C16 H25 N5 O S) FORMUL 4 EDO 3(C2 H6 O2) FORMUL 8 HOH *161(H2 O) HELIX 1 1 MET A 9 LYS A 19 1 11 HELIX 2 2 GLY A 51 LYS A 67 1 17 HELIX 3 3 VAL A 102 GLY A 106 5 5 HELIX 4 4 ASP A 122 LEU A 136 1 15 HELIX 5 5 GLY A 154 PHE A 165 1 12 HELIX 6 6 GLU A 174 PHE A 185 1 12 HELIX 7 7 GLN A 202 ALA A 230 1 29 HELIX 8 8 MET B 9 LYS B 19 1 11 HELIX 9 9 GLY B 51 LYS B 67 1 17 HELIX 10 10 VAL B 102 GLY B 106 5 5 HELIX 11 11 ASP B 122 LEU B 136 1 15 HELIX 12 12 GLY B 154 PHE B 165 1 12 HELIX 13 13 GLU B 174 PHE B 185 1 12 HELIX 14 14 GLN B 202 ALA B 230 1 29 SHEET 1 A 9 ASP A 21 LEU A 28 0 SHEET 2 A 9 CYS A 31 GLN A 37 -1 O GLN A 37 N ASP A 21 SHEET 3 A 9 GLU A 42 LYS A 47 -1 O LYS A 47 N GLU A 32 SHEET 4 A 9 LYS A 2 GLY A 7 1 N ILE A 5 O LEU A 46 SHEET 5 A 9 VAL A 70 GLY A 79 1 O VAL A 70 N GLY A 4 SHEET 6 A 9 ALA A 168 GLU A 172 -1 O VAL A 171 N GLY A 78 SHEET 7 A 9 ALA A 140 SER A 147 1 N LEU A 144 O VAL A 169 SHEET 8 A 9 ILE A 89 TYR A 97 1 N GLU A 94 O ILE A 145 SHEET 9 A 9 PHE A 119 LYS A 120 -1 O PHE A 119 N THR A 95 SHEET 1 B 8 ASP A 21 LEU A 28 0 SHEET 2 B 8 CYS A 31 GLN A 37 -1 O GLN A 37 N ASP A 21 SHEET 3 B 8 GLU A 42 LYS A 47 -1 O LYS A 47 N GLU A 32 SHEET 4 B 8 LYS A 2 GLY A 7 1 N ILE A 5 O LEU A 46 SHEET 5 B 8 VAL A 70 GLY A 79 1 O VAL A 70 N GLY A 4 SHEET 6 B 8 PHE A 189 ASP A 197 1 O ASP A 197 N GLY A 79 SHEET 7 B 8 ILE A 89 TYR A 97 -1 N VAL A 90 O ARG A 193 SHEET 8 B 8 PHE A 119 LYS A 120 -1 O PHE A 119 N THR A 95 SHEET 1 C 9 ASP B 21 LEU B 28 0 SHEET 2 C 9 CYS B 31 LEU B 38 -1 O GLN B 37 N ASP B 21 SHEET 3 C 9 THR B 41 LYS B 47 -1 O LYS B 47 N GLU B 32 SHEET 4 C 9 ILE B 3 GLY B 7 1 N ILE B 5 O LEU B 46 SHEET 5 C 9 VAL B 70 GLY B 79 1 O VAL B 70 N GLY B 4 SHEET 6 C 9 ALA B 168 GLU B 172 -1 O VAL B 171 N GLY B 78 SHEET 7 C 9 ALA B 140 SER B 147 1 N LEU B 144 O VAL B 169 SHEET 8 C 9 ILE B 89 TYR B 97 1 N VAL B 91 O GLY B 143 SHEET 9 C 9 PHE B 119 LYS B 120 -1 O PHE B 119 N THR B 95 SHEET 1 D 8 ASP B 21 LEU B 28 0 SHEET 2 D 8 CYS B 31 LEU B 38 -1 O GLN B 37 N ASP B 21 SHEET 3 D 8 THR B 41 LYS B 47 -1 O LYS B 47 N GLU B 32 SHEET 4 D 8 ILE B 3 GLY B 7 1 N ILE B 5 O LEU B 46 SHEET 5 D 8 VAL B 70 GLY B 79 1 O VAL B 70 N GLY B 4 SHEET 6 D 8 PHE B 189 ASP B 197 1 O ASP B 197 N GLY B 79 SHEET 7 D 8 ILE B 89 TYR B 97 -1 N VAL B 90 O ARG B 193 SHEET 8 D 8 PHE B 119 LYS B 120 -1 O PHE B 119 N THR B 95 SITE 1 AC1 15 ILE A 50 SER A 76 ALA A 77 GLY A 78 SITE 2 AC1 15 ALA A 150 PHE A 151 ILE A 152 GLU A 172 SITE 3 AC1 15 MET A 173 GLU A 174 SER A 196 ASP A 197 SITE 4 AC1 15 PHE A 207 HOH A 408 PHE B 105 SITE 1 AC2 3 GLU A 94 GLY A 118 HOH A 434 SITE 1 AC3 15 ALA B 8 ILE B 50 SER B 76 ALA B 77 SITE 2 AC3 15 GLY B 78 ALA B 150 PHE B 151 ILE B 152 SITE 3 AC3 15 GLU B 172 MET B 173 GLU B 174 SER B 196 SITE 4 AC3 15 ASP B 197 PHE B 207 HOH B 405 SITE 1 AC4 3 ASN B 153 GLY B 154 GLY B 157 SITE 1 AC5 3 ARG B 23 GLN B 24 THR B 25 CRYST1 68.050 46.610 70.940 90.00 114.78 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014695 0.000000 0.006784 0.00000 SCALE2 0.000000 0.021455 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015526 0.00000